P300增加了CSNK2A1的表达,通过激活PI3K-AKT-mTOR轴加速结直肠癌的进展
1Tumor Surgical Department, Beijing Chuiyangliu Hospital, No.2, Chuiyangliu South Street, Chaoyang District, Beijing, 100022, China.
Experimental cell research
|June 30, 2023
概括
这项研究表明,P300增强了素激酶2α1 (CSNK2A1) 的表达,通过激活PI3K-AKT-mTOR通路来促进结直肠癌 (CRC) 的进展. 沉默CSNK2A1可以抑制CRC细胞的迁移和入侵.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 素激酶2α1 (CSNK2A1) 是已知的瘤基因,但其在结直肠癌 (CRC) 进展中的特定作用尚未完全理解.
- 了解CRC中CSNK2A1的调节机制和下游途径对于开发向疗法至关重要.
研究的目的:
- 研究CSNK2A1在结直肠癌发展和进展中的作用.
- 阐明CSNK2A1表达的调节机制及其在CRC中的下游信号通路.
主要方法:
- 定量实时PCR (RT-qPCR) 和西式斑点检测用于评估CRC细胞系中CSNK2A1的表达.
- 特朗斯韦尔测试评估CSNK2A1对细胞迁移和侵入的影响.
- 免疫光,生物信息学分析和染色体免疫沉 (Ch-IP) 试验,以探索调节机制和蛋白质相互作用.
- 对PI3K-AKT-mTOR信号通路的分析.
主要成果:
- 与正常细胞相比,在多个CRC细胞系中,CSNK2A1mRNA和蛋白质水平显著上调.
- 在CSNK2A1促进体的P300介导的H3K27ac激活被确定为增加CSNK2A1表达的关键驱动因素.
- CSNK2A1的过度表达促进了CRC细胞迁移,入侵和上皮-介质细胞转换 (EMT),而CSNK2A1沉默则逆转了这些效应.
- CSNK2A1激活了PI3K-AKT-mTOR信号通路,并且抑制该通路抑制了CSNK2A1诱导的CRC细胞迁移和入侵.
结论:
- 在P300增强CSNK2A1表达的情况下,存在一个积极的反机制,从而加速CRC进展.
- 通过激活PI3K-AKT-mTOR轴,CSNK2A1在促进CRC转移和EMT方面发挥着关键作用.
- 向CSNK2A1或PI3K-AKT-mTOR通路可能为结直肠癌提供潜在的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


